Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18513462 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed 12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation
Condition: Smoking Cessation
Intervention: Drug: CP-526,555 (varenicline)
2 Completed Human Laboratory Study Of Varenicline in Smokers
Condition: Nicotine Dependence
Interventions: Drug: Placebo;   Drug: Varenicline

Indicates status has not been verified in more than two years